Navigation Links
Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference
Date:3/26/2008

RALEIGH, N.C., March 26 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotechnology industry, announced today that George Schmidt, Vice President in the firm's Sales Practice, will present a workshop at the EyeForPharma Sales Force Effectiveness (SFE) conference. The event will be held from April 2 to 4 at the Centre Convencions Internacional in Barcelona, Spain.

Mr. Schmidt's 90-minute workshop, titled "Positioning Sales Training as a Strategic Leader in Your Organization," is scheduled for Thursday, April 3 at 3:05 pm and is placed in the "Training & Development" track. The workshop will examine the strategic role sales training departments play within the larger commercial organization and suggest strategies to identify the training needs associated with the business- and selling-environment challenges faced by their sales forces.

"The Sales Training function is not always recognized as a strategic contributor at many pharma and biotech companies," Mr. Schmidt explains. "Sales management typically takes an 'act now' approach to working with Sales Training, forcing training managers to address requests on a frequent but ad hoc basis. This mentality makes it difficult for Sales Training to take on a more strategic role in the overall sales organization. To do that, training managers must be proactive and anticipate the needs of the sales force, making strategic recommendations to senior management-sometimes across multiple functions at their company-that address training gaps and communicate results throughout the process," he continued.

George Schmidt has served the sales and marketing needs of pharmaceutical clients covering a wide array of topics, such as sales force effectiveness, resource allocation, marketing strategy, and product positioning. Mr. Schmidt leads the sales training specialty area within the Sales Practice at Campbell Alliance. His understanding of project management and leadership stems from his experience as a sales and marketing consultant and an officer in the US Army. Mr. Schmidt earned an MBA from the Darden Business School at the University of Virginia. He also holds BS degrees in Industrial Management and Economics from Carnegie Mellon University. He is a frequent contributor to Society of Pharmaceutical and Biotech Trainers' FOCUS magazine and serves on its editorial board.

For more information on the EyeForPharma SFE conference, please visit http://www.eyeforpharma.com/sales2008.

Executives from Campbell Alliance speak at many conferences in the US and Europe each year. For a full listing of events, please refer to the company's online conference calendar at http://www.campbellalliance.com/pressroom/eventcalendar.cfm.

About the Sales Practice at Campbell Alliance

A combination of quantitative and qualitative factors must be addressed to get maximum sales force effectiveness, whether you're dealing with a large primary care team or a small specialty sales group. These factors include
-- Deployment (targeting, size, structure, alignment)

-- Support (marketing support, communications, sales force automation)

-- Motivation (incentive compensation, recognition, professional

development, confidence in management)

-- Ability (recruiting, training, assessment) The Sales practice at Campbell Alliance helps pharmaceutical and biotech companies take a total approach to sales force optimization-and realize superior sales results-through such service offerings as sales strategy, sales analytics, sales force effectiveness, sales training, and sales force assessment.

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, and Atlanta, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com.

CONTACT:

James Forte

Director, Public and Media Relations

Campbell Alliance

919-844-7100, extension 7195

jforte@campbellalliance.com


'/>"/>
SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference
2. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
3. Campbell Alliance Named Best Place to Work by Triangle Business Journal
4. Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver
5. Campbell Alliance Launches New Practice Area Focused on Trade and Distribution
6. Campbell Alliance Trade and Distribution Practice to Chair CBI 3rd Annual Fee for Service and EDI Data Management Conference
7. Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
8. Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBIs Early Commercialization Conference
9. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
10. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
11. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... DelveInsight,s, "Protein-Tyrosine Phosphatase ... in depth insights on the pipeline drugs ... Phosphatase 1B (PTP1B) Inhibitors. The DelveInsight,s Report ... of development including Discovery, Pre-clinical, IND, Phase ... Report covers the product clinical trials information ...
(Date:2/8/2016)... February 8, 2016 ... Limited, an innovation-driven oncology company developing next generation ... toxic, today announced that chairman emeritus of Tata ... in the company as part of the first ... existing investors Navam Capital and Aarin Capital. ...
(Date:2/8/2016)... ... 08, 2016 , ... Information Management Services ( IMS ) is pleased to ... completely new technical foundation and is so significant it was endowed with a new ... speed for search results, a streamlined layout and a more intuitive format for navigating ...
(Date:2/8/2016)... an active R&D program for the development of future natural ... a unique research and development center in Israel ... products. Stockton has a variety of ... and is active in more than 35 counties worldwide. ... flagship product Timorex Gold ® is used ...
Breaking Biology Technology:
(Date:1/22/2016)... Jan. 22, 2016 ... of the "Global Biometrics Market in ... offering. --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ... "Global Biometrics Market in Retail Sector 2016-2020" ... --> Research and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ...
(Date:1/20/2016)... SAN JOSE, Calif. , Jan. 20, 2016 ... leading developer of human interface solutions, today announced ... touch controller solution for wearables and small screen ... appliances such as printers. Supporting round and rectangular ... the S1423 offers excellent performance with moisture on ...
(Date:1/13/2016)... , January 13, 2016 /PRNewswire/ ... announced the addition of the  "India ... Estimation & Forecast (2015-2020)"  report ... http://www.researchandmarkets.com/research/7h6hnn/india_biometrics ) has announced the addition ... Identification Market - Estimation & Forecast ...
Breaking Biology News(10 mins):